Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Sernova Corp Common Shares (AMEX: SEOVF) | Delayed: 0.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.09 | 52 Week High | $0.31 | |||
| Open | $0.09 | 52 Week Low | $0.16 | |||
| Day High | $0.09 | P/E | N/A | |||
| Day Low | $0.09 | EPS | $0.00 | |||
| Volume | 101,693 | |||||
| Sinovac Biotech, Ltd (NASDAQ: SVA) | Delayed: 6.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.47 | 52 Week High | $7.16 | |||
| Open | $0.08 | 52 Week Low | $4.38 | |||
| Day High | $6.47 | P/E | N/A | |||
| Day Low | $6.47 | EPS | $-0.08 | |||
| Volume | 39,200 | |||||
